Gsa Capital Partners LLP Precigen, Inc. Transaction History

Gsa Capital Partners LLP

$1.19 Billion
Q1 2024

A detailed history of Gsa Capital Partners LLP transactions in Precigen, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 223,288 shares of PGEN stock, worth $312,603. This represents 0.03% of its overall portfolio holdings.

Number of Shares

223,288

Previous 571,463 60.93%

Holding current value

$312,603

Previous $765,000 57.78%

% of portfolio

0.03%

Previous 0.07%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$1.21 - $1.75 $421,291 - $609,306	-348,175 Reduced 60.93%	223,288 $323,000
Q4 2023 Feb 16, 2024	BUY	$0.89 - $1.41 $210,639 - $333,710	236,674 Added 70.69%	571,463 $765,000
Q3 2023 Nov 15, 2023	BUY	$1.08 - $1.85 $361,572 - $619,359	334,789 New	334,789 $475,000
Q1 2023 May 12, 2023	BUY	$0.88 - $2.19 $21,788 - $54,224	24,760 Added 9.99%	272,705 $289,000
Q4 2022 Feb 13, 2023	SELL	$1.27 - $2.26 $144,277 - $256,745	-113,604 Reduced 31.42%	247,945 $377,000

Q3 2022 Nov 14, 2022	SELL	$1.41 - $2.79 $197,755 - $391,303	-140,252 Reduced 27.95%	361,549 $766,000
Q2 2022 Aug 09, 2022	BUY	$1.15 - $2.53 $197,757 - $435,066	171,963 Added 52.14%	501,801 $672,000
Q1 2022 May 11, 2022	BUY	$1.91 - $3.98 $382,742 - $797,548	200,389 Added 154.8%	329,838 $696,000
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $346,303 - $539,566	98,103 Added 312.97%	129,449 $480,000
Q3 2021 Nov 12, 2021	BUY	$4.99 - $6.55 $156,416 - $205,316	31,346 New	31,346 $156,000
Q1 2021 May 10, 2021	SELL	$6.74 - $10.95 $174,539 - $283,561	-25,896 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$3.75 - $10.56 $644,347 - $1.81 Million	-171,826 Reduced 86.9%	25,896 $264,000
Q3 2020 Nov 06, 2020	BUY	$3.5 - $6.2 $692,027 - $1.23 Million	197,722 New	197,722 $692,000
Q2 2020 Aug 11, 2020	SELL	$2.16 - $5.46 $274,458 - $693,769	-127,064 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$1.46 - $7.19 $185,513 - $913,590	127,064 New	127,064 $432,000

Others Institutions Holding PGEN

# of Institutions

141

Shares Held

145M

Call Options Held

208K

Put Options Held

43.7K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $291M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Precigen, Inc. Transaction History